---
title: "Xtant Medical Holdings, Inc. (XTNT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/XTNT.US.md"
symbol: "XTNT.US"
name: "Xtant Medical Holdings, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T16:42:05.614Z"
locales:
  - [en](https://longbridge.com/en/quote/XTNT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XTNT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XTNT.US.md)
---

# Xtant Medical Holdings, Inc. (XTNT.US)

## Company Overview

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [xtantmedical.com](https://xtantmedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: B (0.36)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 10 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -0.32% |  |
| Net Profit YoY | 115.23% |  |
| P/B Ratio | 1.32 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 64291331.34 |  |
| Revenue | 121907000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.95% | C |
| Profit Margin | 1.50% | C |
| Gross Margin | 57.32% | B |
| Revenue YoY | -0.32% | D |
| Net Profit YoY | 115.23% | A |
| Total Assets YoY | -18.61% | E |
| Net Assets YoY | 10.76% | B |
| Cash Flow Margin | 501.31% | A |
| OCF YoY | -0.32% | D |
| Turnover | 1.40 | A |
| Gearing Ratio | 37.69% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Xtant Medical Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-0.32%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "115.23%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.32",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "64291331.34",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "121907000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.95%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "1.50%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "57.32%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-0.32%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "115.23%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-18.61%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "10.76%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "501.31%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-0.32%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "1.40",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "37.69%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 35.21 | 16/45 | 55.56 | 48.08 | 16.05 |
| PB | 1.32 | 14/45 | 2.13 | 1.80 | 1.62 |
| PS (TTM) | 0.53 | 7/45 | 0.78 | 0.67 | 0.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-13T04:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 67% |
| Overweight | 1 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.46 |
| Highest Target | 1.20 |
| Lowest Target | 1.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/XTNT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/XTNT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/XTNT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/XTNT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**